Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookGuidelines to Antiretroviral Drug Therapy in Kenya (WHO; 2001; 78 pages)
View the documentFOREWORD
View the documentACKNOWLEDGMENT
close this folderCHAPTER ONE: INITIATING ANTIRETROVIRAL THERAPY
View the document1.1 Introduction
View the document1.2 Guidelines to making a diagnosis of HIV infection
View the document1.3 Laboratory Diagnosis of HIV infection
View the document1.4 Goals of therapy
View the document1.5 When to start therapy
View the document1.6 Risks and benefits of delayed initiation of therapy and of early therapy in the Asymptomatic HIV-Infected Patient
View the document1.7 Antiretroviral profile
View the document1.8 What drug combination to start with?
Open this folder and view contentsCHAPTER TWO: MONITORING AND CHANGING THERAPY
Open this folder and view contentsCHAPTER THREE: PHARMACOTHERAPEUTICS OF ARVS
Open this folder and view contentsCHAPTER FOUR: GUIDELINES FOR THE USE OF ANTIRETROVIRAL DRUGS IN PAEDIATRIC HIV INFECTION
Open this folder and view contentsCHAPTER FIVE: MANAGEMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTED PREGNANT WOMEN AND PREVENTION OF MOTHER TO CHILD TRANSMISSION (MTCT) OF HIV
Open this folder and view contentsCHAPTER SIX: SPECIAL CONSIDERATIONS
Open this folder and view contentsCHAPTER SEVEN: WHEN TO STOP TREATMENT (INTERRUPTIONS)
Open this folder and view contentsCHAPTER EIGHT: GUIDELINES FOR POST EXPOSURE PROPHYLAXIS
View the documentCHAPTER NINE: ACCESS TO DRUGS IN KENYA
Open this folder and view contentsAPPENDICES
View the documentBACK COVER
 

1.7 Antiretroviral profile

The gold standard of anti-retroviral therapy is HAART.

What is HAART?

Highly Active Anti-retroviral Therapy is a combination of three or more antiretroviral drugs in the treatment of HIV infection. These antiretroviral drugs fall in three different classes and work at different sites on the HIV virus.

Nucleoside analogue Reverse
Transcriptase Inhibitors (NRTIs)

The first effective class of anti-retroviral, drugs was the nucleoside analogues. They act by incorporating themselves into the DNA of the virus thereby stopping the building process. The resulting DNA is incomplete.

Name and class of drug

Strength of preparation

Adult Dosing

Nucleoside analogue Reverse Transcriptase Inhibitors (NRTIs)

   

Zidovudine (AZT)**

Capsules, 100mg

250-300mg BID

Didanosine (ddl)**

Tablets, 100mg, 25mg

100-200mg BD

Lamivudine (3TC)**

Tablets, 150mg

150mg BID

Stavudine (d4T)**

Capsules, 40mg

40mg BID

 

Capsules, 30mg

30mg BID

Zalcitabine (ddC)

Tablets, 0.75mg

0.75mg TO

Abacavir (ABC)

Capsules, 300mg

300mg BD

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

The second class of antiretroviral drugs are the Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) which stop HIV production by binding directly onto reverse transcriptase preventing the conversion of RNA to DNA. These drugs are called non-nucleoside inhibitors because even though they work at the same stage as nucleoside analogues, they act in a completely different way.

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

   

Efavirenz (EFZ)

Capsules, 200mg

600mg OD

Nevirapine (NVP)

Tablets, 200mg

200mg BD

Delavirdine (DLV)

Capsules, 100mg

600mg BD

Protease Inhibitors

The last class of antiretroviral drugs are the Protease Inhibitors which work at the last stage of the virus reproduction cycle. They prevent HIV virus from being successfully assembled and released the infected cell.

Protease Inhibitors

   

Saquinavir hard- gel (SQV)

Capsules, 200mg

600Jmg TID

Saquinavir soft gel (SQV)

Capsules, 200mg

1200mg TID

Ritonavir** (RTV)

Capsules, 100mg

600mg BD

Indinavir (IDV)

Capsules, 200mg

800mg TID

Nelfinavir** (NFV)

Tablets, 250mg

1250mg BD or 750mg TDS

Amprenavir^ (AMV)

Tablets, 300mg

1200mg BD

Lopinavir + Ritonavir^

Capsules (13.3mg Lopinavir + 33.3mg Ritonavir).

400mg Lopinavir + 100mg Ritovavir BD

Drugs marked ^ are not currently available in Kenya and drugs marked ** are available in pediatrics formulations.

to previous sectionto next section

Please provide your feedback English  |  French